The three-year shareholder returns and company earnings persist lower as Bloomage BioTechnology stock falls a further 3.5 percent in past week - Simply Wall St
688363 Stock | 48.35 1.05 2.13% |
About 62% of Bloomage Biotechnology's investor base is looking to short. The analysis of overall sentiment of trading Bloomage Biotechnology Corp stock suggests that many investors are alarmed at this time. The current market sentiment, together with Bloomage Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Bloomage Biotechnology stock news signals to limit their universe of possible portfolio assets.
Bloomage |
The three-year shareholder returns and company earnings persist lower as Bloomage BioTechnology stock falls a further 3.5 percent in past week Simply Wall St
Read at news.google.com
Bloomage Biotechnology Fundamental Analysis
We analyze Bloomage Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bloomage Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bloomage Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Bloomage Biotechnology is currently under evaluation in target price category among its peers.
Bloomage Biotechnology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bloomage Biotechnology stock to make a market-neutral strategy. Peer analysis of Bloomage Biotechnology could also be used in its relative valuation, which is a method of valuing Bloomage Biotechnology by comparing valuation metrics with similar companies.
Peers
Bloomage Biotechnology Related Equities
Complementary Tools for Bloomage Stock analysis
When running Bloomage Biotechnology's price analysis, check to measure Bloomage Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bloomage Biotechnology is operating at the current time. Most of Bloomage Biotechnology's value examination focuses on studying past and present price action to predict the probability of Bloomage Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bloomage Biotechnology's price. Additionally, you may evaluate how the addition of Bloomage Biotechnology to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |